Oruka Therapeutics (ORKA) Treasury Shares (2013 - 2026)

Oruka Therapeutics' Treasury Shares history runs 11 years deep, the most recent figure standing at $2.8 million for Q1 2026.

• On a quarterly basis, Treasury Shares fell 9.39% year-over-year to $2.8 million in Q1 2026; TTM through Mar 2026 was $2.8 million, a 9.39% decrease from a year earlier, with the FY2025 full-year figure at $3.0 million, down 0.81% from the prior year.
• Treasury Shares declined to $2.8 million in Q1 2026 per ORKA's latest filing, from $3.0 million in the prior quarter.
• Across five years, Treasury Shares topped out at $3.1 million in Q3 2024 and bottomed at $91000.0 in Q4 2022.
• The 5-year median for Treasury Shares is $2.8 million (2026), against an average of $1.9 million.
• Across the five-year window, Treasury Shares jumped 3256.44% in 2024 and declined 9.39% in 2026, its largest moves.
• Year by year, Treasury Shares stood at $91000.0 in 2022, then changed by 0.0% to $91000.0 in 2023, then jumped by 2325.88% to $2.2 million in 2024, then jumped by 37.23% to $3.0 million in 2025, then retreated by 8.65% to $2.8 million in 2026.
• Per Business Quant, the three latest ORKA Treasury Shares figures stand at $2.8 million (Q1 2026), $3.0 million (Q4 2025), and $3.1 million (Q3 2025).